India generic drugmakers' woes put new focus on quality over price

March 25 (Reuters) - A spate of regulatory warnings for India's generic drug manufacturers will add a new emphasis on the quality of such medicines in an industry long dominated by the ability to deliver treatments as cheaply as possible, analysts say.

Read more here >> Reuters | Quail eggs